| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 83.936 | 94.301 | 66.894 | - | - | - | - | - | - | - |
| Total Income - EUR | 83.937 | 94.358 | 77.691 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 10.309 | 49.173 | 59.102 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 73.627 | 45.185 | 18.589 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 71.038 | 44.242 | 17.812 | - | - | - | - | - | - | - |
| Employees | 0 | 2 | 2 | - | - | - | - | - | - | - |
Check the financial reports for the company - Biotek Technologies Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.388 | 14.434 | 1.493 | - | - | - | - | - | - | - |
| Current Assets | 81.948 | 127.909 | 34.533 | - | - | - | - | - | - | - |
| Inventories | 0 | 3.178 | 313 | - | - | - | - | - | - | - |
| Receivables | 22.808 | 90.263 | 21.501 | - | - | - | - | - | - | - |
| Cash | 59.140 | 34.469 | 12.719 | - | - | - | - | - | - | - |
| Shareholders Funds | 76.214 | 46.641 | 20.209 | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 55 | - | - | - | - | - | - | - |
| Debts | 7.121 | 95.852 | 2.739 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 68.570 | 13.143 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "161 - 161" | |||||||||
| CAEN Financial Year |
161
|
|||||||||
Comments - Biotek Technologies Srl